Personality and the acute subjective effects of d-amphetamine in humans

Journal of Psychopharmacology

Volumn 27, Issue 3, 2013, Pages 256-264

  Kirkpatrick, Matthew G ^a   Johanson, Chris Ellyn ^b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Humans; Impulsivity; Personality; Subjective effects

Indexed keywords

DEXAMPHETAMINE;

ADDICTION RESEARCH CENTER INVENTORY; ADULT; AROUSAL; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS QUESTIONNAIRE; DRUG RESPONSE; DYSPHORIA; EMOTION; EUPHORIA; FEARLESSNESS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPULSIVENESS; MALE; MULTIDIMENSIONAL PERSONALITY QUESTIONNAIRE BRIEF FORM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROCHEMISTRY; NORMAL HUMAN; PERSONALITY; PRIORITY JOURNAL; PROFILE OF MOOD STATES; QUESTIONNAIRE; REWARD; VOLUNTEER;

ADOLESCENT; ADULT; AROUSAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUPHORIA; FEAR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; PERSONALITY; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; REWARD; YOUNG ADULT;

EID: 84877861800     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112472564     Document Type: Article

References (60)

1. Alessi SM, Greenwald M and Johanson CE (2003) The prediction of individual differences in response to D-amphetamine in healthy adults. Behav Pharmacol 14: 19-32. (Pubitemid 36279022)
2. Belin D, Mar AC, Dalley JW, et al. (2008) High impulsivity predicts the switch to compulsive cocaine-taking. Science 320: 1352-1355. (Pubitemid 351929473)
3. Bergh C, Eklund T, Sodersten P, et al. (1997) Altered dopamine function in pathological gambling. Psychol Med 27: 473-475. (Pubitemid 27139979)
4. Carver CS and Miller CJ (2006) Relations of serotonin function to personality: Current views and a key methodological issue. Psychiatry Res 144: 1-15. (Pubitemid 44332540)
5. Chait LD (1993) Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav Pharmacol 4: 191-199. (Pubitemid 23181738)
6. Cloninger CR (1986) A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 4: 167-226. (Pubitemid 17216108)
7. Comer SD, Bickel WK, Yi R, et al. (2010) Human behavioral pharmacology, past, present, and future: Symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol 21: 251-277.
8. Corr PJ and Kumari V (2000) Individual differences in mood reactions to d-amphetamine: A test of three personality factors. J Psychopharmacol 14: 371-377. (Pubitemid 32059782)
9. Crabbe JC, Jarvik LF, Liston EH, et al. (1983) Behavioral responses to amphetamines in identical twins. Acta Genet Med Gemellol (Roma) 32: 139-149. (Pubitemid 14229381)
10. Dalley JW, Fryer TD, Brichard L, et al. (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270. (Pubitemid 46364262)
11. de Wit H and Phillips TJ (2012) Do initial responses to drugs predict future use or abuse? Neurosci Biobehav Rev 36: 1565-1576.
12. de Wit H, Uhlenhuth EH and Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16: 341-360. (Pubitemid 16168232)
13. Depue RA and Collins PF (1999) Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22: 491-517; discussion 518-469. (Pubitemid 29381711)
14. Depue RA, Luciana M, Arbisi P, et al. (1994) Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol 67: 485-498.
15. Diergaarde L, Pattij T, Poortvliet I, et al. (2008) Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63: 301-308.
16. Eysenck SB and Eysenck HJ (1967) Physiological reactivity to sensory stimulation as a measure of personality. Psychol Rep 20: 45-46.
17. Fischman MW and Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86: 1563-1570.
18. Griffiths RR, Bigelow GE and Ator NA (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend 70(3 Suppl): S41-S54. (Pubitemid 36577514)
19. Hart AB, de Wit H and Palmer AA (2012) Genetic factors modulating the response to stimulant drugs in humans. Curr Top Behav Neurosci [Epub ahead of print].
20. Hatsukami DK and Fischman MW (1996) Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 276: 1580-1588. (Pubitemid 26384741)
21. Hutchison KE, Wood MD and Swift R (1999) Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans. Exp Clin Psychopharmacol 7: 493-501.
22. Jasinski DR (1991) History of abuse liability testing in humans. Br J Addict 86: 1559-1562.
23. Johanson CE and Uhlenhuth EH (1980) Drug preference and mood in humans: d-amphetamine. Psychopharmacology (Berl) 71: 275-279. (Pubitemid 11194004)
24. Justice AJ and De Wit H (2000) Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66: 509-515. (Pubitemid 30440843)
25. Kelly TH, Robbins G, Martin CA, et al. (2006) Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) 189: 17-25. (Pubitemid 44607256)
26. Kim SJ, Kim YS, Lee HS, et al. (2006) An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. J Neural Transm 113: 877-886. (Pubitemid 43962781)
27. Laine TP, Ahonen A, Rasanen P, et al. (2001) Dopamine transporter density and novelty seeking among alcoholics. J Addict Dis 20: 91-96. (Pubitemid 33095751)
28. Mann JJ, Brent DA and Arango V (2001) The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system. Neuropsychopharmacology 24: 467-477. (Pubitemid 32244308)
29. Marinelli M and White FJ (2000) Enhanced vulunerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20: 8876-8885.
30. Martin WR, Sloan JW, Sapira JD, et al. (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245-258.
31. Marusich JA and Bardo MT (2009) Differences in impulsivity on a delay-discounting task predict self-administration of a low unit dose of methylphenidate in rats. Behav Pharmacol 20: 447-454.
32. Mattay VS, Goldberg TE, Fera F, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100: 6186-6191. (Pubitemid 36576952)
33. McNair D, Lorr M and Droppleman L (1971) Profile of Mood States. San Diego: Educational and Industrial Testing Service
34. Moeller FG, Dougherty DM, Barratt ES, et al. (2001) The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 21: 193-198. (Pubitemid 34037109)
35. Moresco FM, Dieci M, Vita A, et al. (2002) In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: A positron emission tomography study. Neuroimage 17: 1470-1478. (Pubitemid 35333866)
36. Nurnberger JI, Jr., Gershon ES, Simmons S, et al. (1982) Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology 7: 163-176. (Pubitemid 12006385)
37. Oswald LM, Wong DF, Zhou Y, et al. (2007) Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 36: 153-166. (Pubitemid 46617942)
38. Patrick CJ, Curtin JJ and Tellegen A (2002) Development and validation of a brief form of the Multidimensional Personality Questionnaire. Psychol Assess 14: 150-163. (Pubitemid 34538733)
39. Peirson AR, Heuchert JW, Thomala L, et al. (1999) Relationship between serotonin and the temperament and character inventory. Psychiatry Res 89: 29-37.
40. Perkins KA, Gerlach D, Broge M, et al. (2000) Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Exp Clin Psychopharmacol 8: 462-471.
41. Perry JL, Larson EB, German JP, et al. (2005) Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 178: 193-201. (Pubitemid 40379214)
42. Perry JL, Nelson SE and Carroll ME (2008) Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 16: 165-177. (Pubitemid 351680709)
43. Piazza PV, Deminière JM, Le Moal M, et al. (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513. (Pubitemid 19243245)
44. Poulos CX, Le AD and Parker JL (1995) Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol 6: 810-814.
45. Reif A and Lesch KP (2003) Toward a molecular architecture of personality. Behav Brain Res 139: 1-20. (Pubitemid 36298488)
46. Reist C, Helmeste D, Albers L, et al. (1996) Serotonin indices and impulsivity in normal volunteers. Psychiatry Res 60: 177-184. (Pubitemid 26140176)
47. Sax KW and Strakowski SM (1998) Enhanced behavioral response to repeated d-amphetamine and personality traits in humans. Biol Psychiatry 44: 1192-1195. (Pubitemid 28547155)
48. Silberman EK, Reus VI, Jimerson DC, et al. (1981) Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry 138: 1302-1307. (Pubitemid 12201188)
49. Simon SL, Richardson K, Dacey J, et al. (2002) A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21: 35-44. (Pubitemid 35203852)
50. Stoops WW, Lile JA, Robbins CG, et al. (2007) The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: Influence of sensation-seeking status. Addict Behav 32: 1177-1188. (Pubitemid 46497548)
51. Swann AC (2003) Neuroreceptor mechanisms of aggression and its treatment. J Clin Psychiatry 64 (Suppl 4): 26-35. (Pubitemid 36418560)
52. Tellegen A (1982) Brief Manual for the Multtdimensional Personality Questionnaire. Unpublished manuscript, University of Minnesota, Minneapolis.
53. Tellegen A (1985) Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report. In: Tuma AH and Maser JD (eds) Anxiety and the Anxiety Disorders. Hillsdale, NJ: Erlbaum, pp.681-706.
54. Uhlenhuth EH, Johanson CE, Kilgore K, et al. (1981) Drug preference and mood in humans: Preference for d-amphetamine and subject characteristics. Psychopharmacology (Berl) 74: 191-194. (Pubitemid 11126554)
55. Veenstra-VanderWeele J, Qaadir A, et al. (2006) Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31: 1056-1063.
56. Volkow ND, Wang GJ, Newcorn JH, et al. (2011) Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry 16: 1147-1154.
57. Wade TR, de Wit H and Richards JB (2000) Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) 150: 90-101. (Pubitemid 30350818)
58. White TL and Depue RA (1999) Differential association of traits of fear and anxiety with norepinephrine- and dark-induced pupil reactivity. J Pers Soc Psychol 77: 863-877.
59. White TL, Justice AJ and de Wit H (2002) Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73: 729-741. (Pubitemid 35251831)
60. White TL, Lott DC and de Wit H (2006) Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology 31: 1064-1074.